Accelerating Medicines Partnership (AMP)
GPTKB entity
Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
public-private partnership
|
| gptkbp:abbreviation |
gptkb:AMP
|
| gptkbp:collaboratesWith |
gptkb:Food_and_Drug_Administration
multiple academic institutions |
| gptkbp:coordinates |
gptkb:National_Institutes_of_Health
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:firstReleased |
2014
|
| gptkbp:focusArea |
gptkb:Alzheimer's_disease
gptkb:Parkinson's_disease gptkb:systemic_lupus_erythematosus gptkb:type_2_diabetes rheumatoid arthritis |
| gptkbp:foundedBy |
gptkb:National_Institutes_of_Health
non-profit organizations biopharmaceutical companies |
| https://www.w3.org/2000/01/rdf-schema#label |
Accelerating Medicines Partnership (AMP)
|
| gptkbp:purpose |
accelerate the discovery of new therapies
|
| gptkbp:website |
https://www.nih.gov/research-training/accelerating-medicines-partnership-amp
|
| gptkbp:bfsParent |
gptkb:AMP_Bespoke_Gene_Therapy_Consortium
gptkb:AMP_Rheumatoid_Arthritis_and_Systemic_Lupus_Erythematosus |
| gptkbp:bfsLayer |
7
|